Gene · 1643
Papers2,095
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,095
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy. | Front Oncol | 2022 | 36568213 | PubTator, text mining | PubMed |
| The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma. | Int J Mol Sci | 2022 | 36555311 | PubTator, text mining | PubMed |
| The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies. | Cells | 2022 | 36552824 | PubTator, text mining | PubMed |
| Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy. | Front Oncol | 2022 | 36531044 | PubTator, text mining | PubMed |
| Cooperative interaction between AAG and UV-DDB in the removal of modified bases. | Nucleic Acids Res | 2022 | 36511855 | PubTator, text mining | PubMed |
| Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives. | Int J Mol Sci | 2022 | 36499737 | PubTator, text mining | PubMed |
| The XPA Protein-Life under Precise Control. | Cells | 2022 | 36496984 | PubTator, text mining | PubMed |
| SIRT6 in Aging, Metabolism, Inflammation and Cardiovascular Diseases. | Aging Dis | 2022 | 36465178 | PubTator, text mining | PubMed |
| Cellular and molecular effects of PNCK, a non-canonical kinase target in renal cell carcinoma. | iScience | 2022 | 36465101 | PubTator, text mining | PubMed |
| Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations. | Front Immunol | 2022 | 36439142 | PubTator, text mining | PubMed |
| Single-cell transcriptomic characterization reveals the landscape of airway remodeling and inflammation in a cynomolgus monkey model of asthma. | Front Immunol | 2022 | 36439114 | PubTator, text mining | PubMed |
| Genetic Characterization in High-Risk Individuals from a Low-Resource City of Peru. | Cancers (Basel) | 2022 | 36428697 | PubTator, text mining | PubMed |
| A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer. | Front Oncol | 2022 | 36408135 | PubTator, text mining | PubMed |
| ALDH1: A potential therapeutic target for cancer stem cells in solid tumors. | Front Oncol | 2022 | 36387165 | PubTator, text mining | PubMed |
| mRNA, lncRNA, and circRNA expression profiles in a new aortic dissection murine model induced by hypoxia and Ang II. | Front Cardiovasc Med | 2022 | 36386298 | PubTator, text mining | PubMed |
| Identification and validation of ubiquitin-proteasome system related genes as a prognostic signature for papillary renal cell carcinoma. | Aging (Albany NY) | 2022 | 36385010 | PubTator, text mining | PubMed |
| Early recruitment of PARP-dependent m8A RNA methylation at DNA lesions is subsequently accompanied by active DNA demethylation. | RNA Biol | 2022 | 36382943 | PubTator, text mining | PubMed |
| Insight into the physiological and pathological roles of USP44, a potential tumor target (Review). | Oncol Lett | 2022 | 36380875 | PubTator, text mining | PubMed |
| Genome-Wide Transcriptional Profiling Reveals PHACTR1 as a Novel Molecular Target of Resveratrol in Endothelial Homeostasis. | Nutrients | 2022 | 36364780 | PubTator, text mining | PubMed |
| Potential Anti-Tumor Activity of Nardoguaianone L Isolated from Nardostachys jatamansi DC. in SW1990 Cells. | Molecules | 2022 | 36364317 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1643/papers?page=13